LOW-DOSE METFORMIN IN THE TREATMENT OF TYPE-II NON-INSULIN-DEPENDENT DIABETES - CLINICAL AND METABOLIC EVALUATIONS

被引:27
作者
GREGORIO, F
AMBROSI, F
MARCHETTI, P
CRISTALLINI, S
NAVALESI, R
BRUNETTI, P
FILIPPONI, P
机构
[1] UNIV PERUGIA,IST CLIN MED 1,CATTEDRA MALATTIE RICAMBIO,I-06100 PERUGIA,ITALY
[2] UNIV PISA,IST CLIN MED 2,CATTEDRA MALATTIE RICAMBIOL,I-56100 PISA,ITALY
[3] UNIV PERUGIA,IST PATOL SPECIALE MED,I-06100 PERUGIA,ITALY
来源
ACTA DIABETOLOGICA LATINA | 1990年 / 27卷 / 02期
关键词
Glycemic control; Insulin receptors; Intermediate metabolites; Metformin;
D O I
10.1007/BF02581286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low doses of metformin (500 mg twice daily) were administered to 20 diabetic patients, combined with the original sulfonylurea treatment which had become ineffective even at full dosage. After 1 and 5 weeks, the effects of the drug on glycemic control, blood intermediate metabolites and monocyte insulin receptors were monitored. Metformin clearly improved glycemic control by reducing both fasting blood glucose from 189.88±21.11 mg/dl to 131.12±16.02 mg/dl after 1 week and to 130.11±13.29 mg/dl after 5 weeks (p<0.025 both after 1 and 5 weeks); the diurnal blood glucose average fell from 235.33±24.11 mg/dl to 174.66±23.45 mg/dl (p<0.0025) after 1 week and to 177.65±21.71 mg/dl (p<0.0005) after 5 weeks. Consequently both blood glycosylated hemoglobin (p=n.s. after 1 week, p<0.025 after 5 weeks) and serum fructosamine (p<0.0025 after both 1 and 5 weeks) also decreased after metformin treatment. No change in plasma insulin and C-peptide levels was reported and no modification in diurnal rhythms of blood lactate, pyruvate, alanine glycerol and β-OH-butyrate was detected at any time during metformin treatment. All the changes documented in the binding values were already complete at the end of the first week: insulin binding to monocytes increased slightly but significantly (p<0.05) and the number of receptors per cell rose (p<0.05) but could not be correlated to any index of glycemic control. These data suggest that the antidiabetic action of metformin is neither related to its lactate-increasing activity nor does it depend upon its inducing an increase in insulin binding values. This metformin-related hypoglycemic effect might be the result, at least in part, of a reduced oxidative phosphorylation without inhibition of hepatic guconeogenesis and/or of decreased hepatic glucose output. Moreover, our data are also consistent with the hypothesis that metformin might affect insulin action at a post-receptor level. © 1990 Casa Editrica «il Ponte».
引用
收藏
页码:139 / 155
页数:17
相关论文
共 41 条
[21]   EFFECT OF METFORMIN ON INSULIN-RECEPTOR BINDING AND GLYCEMIC CONTROL IN TYPE-II DIABETES [J].
LORD, JM ;
WHITE, SI ;
BAILEY, CJ ;
ATKINS, TW ;
FLETCHER, RF ;
TAYLOR, KG .
BRITISH MEDICAL JOURNAL, 1983, 286 (6368) :830-831
[22]  
MARCHETTI P, 1987, J ENDOCRINOL INVEST, V10, P154
[23]   COMPARATIVE EFFECTS OF PHENFORMIN, METFORMIN AND GLIBENCLAMIDE ON METABOLIC RHYTHMS IN MATURITY-ONSET DIABETICS [J].
NATTRASS, M ;
TODD, PG ;
HINKS, L ;
LLOYD, B ;
ALBERTI, KGMM .
DIABETOLOGIA, 1977, 13 (02) :145-152
[24]   METABOLIC EFFECTS OF COMBINED SULFONYLUREA AND METFORMIN THERAPY IN MATURITY-ONSET DIABETICS [J].
NATTRASS, M ;
HINKS, L ;
SMYTHE, P ;
TODD, PG ;
ALBERTI, KGMM .
HORMONE AND METABOLIC RESEARCH, 1979, 11 (05) :332-337
[25]   EFFECT OF METFORMIN ON INSULIN-STIMULATED GLUCOSE-TURNOVER AND INSULIN BINDING TO RECEPTORS IN TYPE-II DIABETES [J].
NOSADINI, R ;
AVOGARO, A ;
TREVISAN, R ;
VALERIO, A ;
TESSARI, P ;
DUNER, E ;
TIENGO, A ;
VELUSSI, M ;
DELPRATO, S ;
DEKREUTZENBERG, S ;
MUGGEO, M ;
CREPALDI, G .
DIABETES CARE, 1987, 10 (01) :62-67
[26]   INSULIN RESISTANCE AND INSULIN ACTION - AN INVITRO AND INVIVO PERSPECTIVE [J].
OLEFSKY, JM .
DIABETES, 1981, 30 (02) :148-162
[27]   EFFECT OF METFORMIN ON INSULIN BINDING TO RECEPTORS IN CULTURED HUMAN-LYMPHOCYTES AND CANCER-CELLS [J].
PEZZINO, V ;
TRISCHITTA, V ;
PURRELLO, F ;
VIGNERI, R .
DIABETOLOGIA, 1982, 23 (02) :131-135
[28]  
PIETROPAOLO M, 1987, G ITAL DIABETOL, V7, P319
[29]   INSULIN-RECEPTOR BINDING TO MONOCYTES, INSULIN-SECRETION, AND GLUCOSE-TOLERANCE FOLLOWING METFORMIN TREATMENT - RESULTS OF A DOUBLE-BLIND CROSSOVER STUDY IN TYPE-II DIABETICS [J].
PRAGER, R ;
SCHERNTHANER, G .
DIABETES, 1983, 32 (12) :1083-1086
[30]  
PRAGER R, 1986, DIABETES METAB, V12, P346